Wolverine Asset Management’s Aspire Biopharma Warrant ASBPW Stock Holding History

Wolverine Asset Management’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.27K	Hold	197,144	–	–	﹤0.01%	1519
2025 Q4	$3.25K	Hold	197,144	–	–	﹤0.01%	1507
2025 Q3	$5.89K	Buy	197,144 +1,200	+0.6%	+$61	﹤0.01%	1420
2025 Q2	$8.76K	Hold	195,944	–	–	﹤0.01%	1386
2025 Q1	$13.3K	Sell	195,944 -205,600	-51%	-$12.4K	﹤0.01%	1282
2024 Q4	$19.1K	Hold	401,544	–	–	﹤0.01%	1298
2024 Q3	$17K	Hold	401,544	–	–	﹤0.01%	1281
2024 Q2	$18K	Hold	401,544	–	–	﹤0.01%	1276
2024 Q1	$12.1K	Hold	401,544	–	–	﹤0.01%	1269
2023 Q4	$24.1K	Hold	401,544	–	–	﹤0.01%	1293
2023 Q3	$20.4K	Hold	401,544	–	–	﹤0.01%	1359
2023 Q2	$20.1K	Hold	401,544	–	–	﹤0.01%	1284
2023 Q1	$16.8K	Hold	401,544	–	–	﹤0.01%	1367
2022 Q4	$32.1K	Hold	401,544	–	–	﹤0.01%	1449
2022 Q3	$44K	Sell	401,544 -4,327	-1%	-$630	﹤0.01%	1630
2022 Q2	$68K	Buy	+405,871	New	+$88.3K	﹤0.01%	1483

Other funds holding ASBPW

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wolverine Asset Management's ASBPW Position: Q1 2026 in Review

Wolverine Asset Management held its Aspire Biopharma Warrant (ASBPW) position steady in Q1 2026 at 197,144 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

Wolverine Asset Management first reported a position in ASBPW in Q2 2022 and has held it in 16 quarters since. The position peaked at $68K in Q2 2022. 29 funds tracked by Wall St. Rank hold ASBPW as of Q1 2026.

Wolverine Asset Management held 197,144 shares of Aspire Biopharma Warrant worth $3.27K as of Q1 2026.
Wolverine Asset Management left its Aspire Biopharma Warrant share count unchanged in Q1 2026.
Aspire Biopharma Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1519 holding.
Wolverine Asset Management first reported a position in Aspire Biopharma Warrant in Q2 2022 and has held it in 16 quarters since.
Wolverine Asset Management's Aspire Biopharma Warrant position peaked at $68K in Q2 2022.
29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.